{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:13:57Z","timestamp":1791209637532,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1741-7015-11-93","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T08:54:13Z","timestamp":1365065653000},"source":"Crossref","is-referenced-by-count":135,"title":["Novel aspects of Sj\u00f6gren\u2019s syndrome in 2012"],"prefix":"10.1186","volume":"11","author":[{"given":"Angela","family":"Tincani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Giulia","family":"Fenini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lojacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nascimbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerigo","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Toniati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"712_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.berh.2012.01.012","volume":"26","author":"Y Peri","year":"2012","unstructured":"Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y: Sj\u00f6gren\u2019s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012, 26: 105-117.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"712_CR2","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM: The geoepidemiology of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2010, 9: A305-A310.","journal-title":"Autoimmun Rev"},{"key":"712_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2012.01.008","volume":"39","author":"JA Ice","year":"2012","unstructured":"Ice JA, Li H, Adrianto I, Lin PC, Kelly JA, Montgomery CG, Lessard CJ, Moser KL: Genetics of Sj\u00f6gren\u2019s syndrome in the genome-wide association era. J Autoimmun. 2012, 39: 57-63.","journal-title":"J Autoimmun"},{"key":"712_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","volume":"11","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM: HLA and Sj\u00f6gren\u2019s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev. 2012, 11: 281-287.","journal-title":"Autoimmun Rev"},{"key":"712_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(93)90130-S","volume":"36","author":"A Roitberg-Tambur","year":"1993","unstructured":"Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, Moutsopoulos HM, Stavropoulos E, Skopouli FN, Margalit H: Molecular analysis of HLA class II genes in primary Sj\u00f6gren\u2019s syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol. 1993, 36: 235-242.","journal-title":"Hum Immunol"},{"key":"712_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/BOR.0b013e32835059e5","volume":"24","author":"M Piram","year":"2012","unstructured":"Piram M, Maldinia C, Mahr A: Effect on race\/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Curr Opin Rheum. 2012, 24: 193-200.","journal-title":"Curr Opin Rheum"},{"key":"712_CR7","doi-asserted-by":"crossref","first-page":"e3821","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f2n P, Sis\u00f2-Almirall A, Bosch X: Primary Sj\u00f6gren syndrome. BMJ. 2012, 344: e3821.","journal-title":"BMJ"},{"key":"712_CR8","volume-title":"Rheumatology","author":"AG Tzioufas","year":"1999","unstructured":"Tzioufas AG, Moutsopoulos HM: Sj\u00f6gren\u2019s syndrome. Rheumatology. Edited by: Klippel JH, Dieppe PA. 1999, Maryland Heights, MI: Mosby, 7.32.1-11, 2","edition":"2"},{"key":"712_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sj\u00f6gren\u2019s syndrome: Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61: 554-558.","journal-title":"Ann Rheum Dis"},{"key":"712_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2011.12.006","volume":"39","author":"C Baldini","year":"2012","unstructured":"Baldini C, Talarico R, Tzioufas AG, Bombardieri S: Classification criteria for Sj\u00f6gren\u2019s syndrome: a critical review. J Autoimmun. 2012, 39: 9-14.","journal-title":"J Autoimmun"},{"key":"712_CR11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2012.08.001","volume":"12","author":"D Guellec","year":"2013","unstructured":"Guellec D, Cornec D, Jousse-Joulin S, Marhadour T, Marcorelles P, Pers JO, Saraux A, Devauchelle-Pensec V: Diagnostic value of labial minor salivary gland biopsy for Sj\u00f6gren\u2019s syndrome: a systematic review. Autoimmun Rev. 2013, 12: 416-420.","journal-title":"Autoimmun Rev"},{"key":"712_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schi\u00f8dt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T: American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012, 64: 475-487.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"712_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE: Sj\u00f6gren\u2019s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren\u2019s Syndrome International Registry. Am J Ophthalmol. 2010, 149: 405-415.","journal-title":"Am J Ophthalmol"},{"key":"712_CR14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ncprheum0864","volume":"4","author":"AG Tzioufas","year":"2008","unstructured":"Tzioufas AG, Moutsopoulos HM: Ultrasonography of salivary glands: an evolving approach for the diagnosis of Sj\u00f6gren\u2019s syndrome. Nat Clin Pract Rheumatol. 2008, 4: 454-455.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"712_CR15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/rheumatology\/ken222","volume":"47","author":"F Salaffi","year":"2008","unstructured":"Salaffi F, Carotti M, Iagnocco A, Luccioli F, Ramonda R, Sabatini E, De Nicola M, Maggi M, Priori R, Valesini G, Gerli R, Punzi L, Giuseppetti GM, Salvolini U, Grassi W: Ultrasonography of salivary glands in primary Sj\u00f6gren\u2019s syndrome: a comparison with contrast sialography and scintigraphy. Rheumatology (Oxford). 2008, 47: 1244-1249.","journal-title":"Rheumatology (Oxford)"},{"key":"712_CR16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/rheumatology\/ker431","volume":"51","author":"V Milic","year":"2012","unstructured":"Milic V, Petrovic R, Boricic I, Radunovic G, Marinkovic-Eric J, Jeremic P, Damjanov N: Ultrasonography of major salivary glands could be an alternative tool to sialoscintigraphy in the American-European classification criteria for primary Sj\u00f6gren\u2019s syndrome. Rheumatology. 2012, 51: 1081-1085.","journal-title":"Rheumatology"},{"key":"712_CR17","first-page":"1442","volume":"24","author":"RA Thoft","year":"1983","unstructured":"Thoft RA, Friend J: The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci. 1983, 24: 1442.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"712_CR18","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA: Report of the National Eye Institute\/Industry Workshop on clinical trials in dry eyes. CLAO J. 1995, 21: 221-232.","journal-title":"CLAO J"},{"key":"712_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"Dry Eye Workshop","year":"2007","unstructured":"Dry Eye Workshop: The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007, 5: 75-92.","journal-title":"Ocul Surf"},{"key":"712_CR20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","volume":"2","author":"ME Stern","year":"2004","unstructured":"Stern ME, Pflugfelder SC: Inflammation in dry eye. Ocul Surf. 2004, 2: 124-130.","journal-title":"Ocul Surf"},{"key":"712_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M, Ramos-Casals R, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M: Primary Sj\u00f6gren\u2019s syndrome. Clinical and immunological disease patterns in a cohort of 400 patients. Medicine. 2002, 81: 270-280.","journal-title":"Medicine"},{"key":"712_CR22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM: Clinical evolution and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome. Seminar Arthritis Rheum. 2000, 29: 296-304.","journal-title":"Seminar Arthritis Rheum"},{"key":"712_CR23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","volume":"40","author":"EJ ter Borg","year":"2011","unstructured":"ter Borg EJ, Risselada AP, Kelder JC: Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 65 patients in the Netherlands. Seminar Arthritis Rheum. 2011, 40: 547-551.","journal-title":"Seminar Arthritis Rheum"},{"key":"712_CR24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2012.01.013","volume":"39","author":"R Seror","year":"2012","unstructured":"Seror R, Bootsma H, Bowman SJ, D\u00f6rner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Theander E, Tzioufas A, Vitali C: Outcome measures for primary Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2012, 39: 97-102.","journal-title":"J Autoimmun"},{"key":"712_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jimenez-Alonso J, Mico ML, Beltran J, Belenguer R, Pallares L, and the GEMESS Study Group: Primary Sj\u00f6gren\u2019s syndrome in Spain. Clinical and immunological expression in 1010 patients. Medicine. 2008, 87: 210-219.","journal-title":"Medicine"},{"key":"712_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","volume":"35","author":"MN Manoussakis","year":"2010","unstructured":"Manoussakis MN, Kapsogeorgou EK: The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2010, 35: 219-224.","journal-title":"J Autoimmun"},{"key":"712_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Meroni PL, Gershwin ME: Primary biliary cirrhosis and Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis. J Autoimmun. 2012, 39: 34-42.","journal-title":"J Autoimmun"},{"key":"712_CR28","first-page":"844","volume":"49","author":"WF Ng","year":"2012","unstructured":"Ng WF, Bowman SJ: Primary Sj\u00f6gren\u2019s syndrome: too dry and too tired. Rheumatology. 2012, 49: 844-853.","journal-title":"Rheumatology"},{"key":"712_CR29","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.lpm.2010.11.002","volume":"40","author":"PY Hatron","year":"2011","unstructured":"Hatron PY, Tillie-Leblond I, Launay D, Hachulla E, Fauchais AL, Wallaert B: Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Presse Med. 2011, 40: e49-e64.","journal-title":"Presse Med"},{"key":"712_CR30","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","volume":"16","author":"N Bossini","year":"2001","unstructured":"Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, Viola BF, Valzorio B, Mazzucchelli C, Cattaneo R, Scolari F, Maiorca R: Clinical and morphological features of kidney involvement in primary Sj\u00f6gren\u2019s syndrome. Nephrol Dial Transplant. 2001, 16: 2328-2336.","journal-title":"Nephrol Dial Transplant"},{"key":"712_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2310\/7750.2010.09033","volume":"15","author":"A Kittridge","year":"2011","unstructured":"Kittridge A, Routhouska SB, Korman NJ: Dermatologic manifestations of Sj\u00f6gren syndrome. J Cutan Med Surg. 2011, 15: 8-14.","journal-title":"J Cutan Med Surg"},{"key":"712_CR32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","volume":"49","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Ouattara B, Gondran G, Lallou\u00e9 F, Petit D, Ly K, Lambert M, Launay D, Loustaud-Ratti V, Bezanahari H, Liozon E, Hachulla E, Jauberteau MO, Vidal E, Hatron PY: Articular manifestations in primary Sj\u00f6gren\u2019s syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford). 2010, 49: 1164-1172.","journal-title":"Rheumatology (Oxford)"},{"key":"712_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e3182329d9c","volume":"46","author":"EC Ebert","year":"2012","unstructured":"Ebert EC: Gastrointestinal and hepatic manifestations of Sj\u00f6gren syndrome. J Clin Gastroenterol. 2012, 46: 25-30.","journal-title":"J Clin Gastroenterol"},{"key":"712_CR34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2012.05.011","volume":"39","author":"CP Mavragani","year":"2012","unstructured":"Mavragani CP, Fragoulis GE, Moutsopoulos HM: Endocrine alterations in primary Sj\u00f6gren\u2019s syndrome: an overview. J Autoimmun. 2012, 39: 354-358.","journal-title":"J Autoimmun"},{"key":"712_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaut.2012.01.003","volume":"39","author":"PP Pavlakis","year":"2012","unstructured":"Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutsopoulos HM, Tzioufas AG, Dalakas MC: Peripheral neuropathies in Sj\u00f6gren\u2019s syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun. 2012, 39: 27-33.","journal-title":"J Autoimmun"},{"key":"712_CR36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/WCO.0b013e32833de6ab","volume":"23","author":"J Chai","year":"2010","unstructured":"Chai J, Logigian EL: Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Curr Opin Neurol. 2010, 23: 509-513.","journal-title":"Curr Opin Neurol"},{"key":"712_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","volume":"39","author":"N Singh","year":"2012","unstructured":"Singh N, Cohen PL: The T cell in Sj\u00f6gren\u2019s syndrome: force majeure, not spectateur. J Autoimmun. 2012, 39: 229-233.","journal-title":"J Autoimmun"},{"key":"712_CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"D Cornec","year":"2012","unstructured":"Cornec D, Devauchelle-Pensec V, Tob\u00f3n GJ, Pers JO, Jousse-Joulin S, Saraux A: B cells in Sj\u00f6gren\u2019s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012, 39: 161-167.","journal-title":"J Autoimmun"},{"key":"712_CR39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.autrev.2011.10.005","volume":"11","author":"MM Varin","year":"2012","unstructured":"Varin MM, Guerrier T, Devauchelle-Pensec V, Jamin C, Youinou P, Pers JO: In Sj\u00f6gren\u2019s syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev. 2012, 11: 252-258.","journal-title":"Autoimmun Rev"},{"key":"712_CR40","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/art.23073","volume":"56","author":"MN Manoussakis","year":"2007","unstructured":"Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM: Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sj\u00f6gren\u2019s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 2007, 56: 3977-3988.","journal-title":"Arthritis Rheum"},{"key":"712_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.autrev.2010.09.022","volume":"10","author":"S Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez S, Aguilera S, Urz\u00faa U, Quest AF, Molina C, Alliende C, Hermoso M, Gonz\u00e1lez MJ: Mechanotransduction and epigenetic control in autoimmune diseases. Autoimmun Rev. 2011, 10: 175-179.","journal-title":"Autoimmun Rev"},{"key":"712_CR42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","volume":"39","author":"AG Tzioufas","year":"2012","unstructured":"Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM: Pathogenesis of Sj\u00f6gren\u2019s syndrome: what we know and what we should learn. J Autoimmun. 2012, 39: 4-8.","journal-title":"J Autoimmun"},{"key":"712_CR43","volume-title":"Oral Pathology - Clinical pathological Correlations","author":"JA Regezi","year":"2012","unstructured":"Regezi JA, Sciubba JJ, Jordan RCK: Oral Pathology - Clinical pathological Correlations. 2012, New York, NY: Elsevier-Saunders, 6","edition":"6"},{"key":"712_CR44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","volume":"21","author":"AG Tzioufas","year":"2007","unstructured":"Tzioufas AG, Voulgarelis M: Update on Sj\u00f6gren\u2019s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol. 2007, 21: 989-1010.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"712_CR45","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar1021","volume":"6","author":"MM Zandbelt","year":"2004","unstructured":"Zandbelt MM, Vogelzangs J, Van De Putte LB, Van Venrooij WJ, Van Den Hoogen FH: Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. 2004, 6: R33-R38.","journal-title":"Arthritis Res Ther"},{"key":"712_CR46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","volume":"39","author":"VK Bournia","year":"2012","unstructured":"Bournia VK, Vlachoyionnapoulos PG: Subgroups of Sj\u00f6gren syndrome patients according to serological profiles. J Autoimmun. 2012, 39: 15-26.","journal-title":"J Autoimmun"},{"key":"712_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","volume":"10","author":"G Hern\u00e1ndez-Molina","year":"2011","unstructured":"Hern\u00e1ndez-Molina G, Leal-Alegre G, Michel-Peregrina M: The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2011, 10: 123-125.","journal-title":"Autoimmun Rev"},{"key":"712_CR48","first-page":"1283","volume":"34","author":"KS Barcellos","year":"2007","unstructured":"Barcellos KS, Nonogaki S, Enokihara MM, Teixeira MS, Andrade LE: Differential expression of Ro\/SSA 60\u2009kDa and La\/SSB, but not Ro\/SSA 52\u2009kDa, mRNA and protein in minor salivary glands from patients with primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2007, 34: 1283-1292.","journal-title":"J Rheumatol"},{"key":"712_CR49","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1196\/annals.1422.044","volume":"1108","author":"M Sisto","year":"2007","unstructured":"Sisto M, Lisi S, Lofrumento D, D'Amore M, Scagliusi P, Mitolo V: Autoantibodies from Sj\u00f6gren\u2019s syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci. 2007, 1108: 418-425.","journal-title":"Ann N Y Acad Sci"},{"key":"712_CR50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2010.06.020","volume":"35","author":"S Lisi","year":"2010","unstructured":"Lisi S, Sisto M, Lofrumento DD, Cucci L, Frassanito MA, Mitolo V, D\u2019Amore M: Pro-inflammatory role of Anti-Ro\/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun. 2010, 35: 160-170.","journal-title":"J Autoimmun"},{"key":"712_CR51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","volume":"10","author":"C Defendenti","year":"2011","unstructured":"Defendenti C, Atzeni F, Spina MF, Grosso S, Cereda A, Guercilena G, Bollani S, Saibeni S, Puttini PS: Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies. Autoimmun Rev. 2011, 10: 150-154.","journal-title":"Autoimmun Rev"},{"key":"712_CR52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","volume":"10","author":"P Ghillani","year":"2011","unstructured":"Ghillani P, Andr\u00e9 C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C: Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60\u2009kDa antibodies: results of a multicentric study. Autoimmun Rev. 2011, 10: 509-513.","journal-title":"Autoimmun Rev"},{"key":"712_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2011.03.001","volume":"10","author":"V Racanelli","year":"2011","unstructured":"Racanelli V, Prete M, Musaraj G, Dammacco F, Perosa F: Autoantibodies to intracellular antigens: generation and pathogenetic role. Autoimmun Rev. 2011, 10: 503-508.","journal-title":"Autoimmun Rev"},{"key":"712_CR54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","volume":"38","author":"F Franceschini","year":"2005","unstructured":"Franceschini F, Cavazzana I: Anti-Ro\/SSA and La\/SSB antibodies. Autoimmunity. 2005, 38: 55-63.","journal-title":"Autoimmunity"},{"key":"712_CR55","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","volume":"35","author":"M Ramos-Casals","year":"2006","unstructured":"Ramos-Casals M, Nardi N, Brito-Zer\u00f3n P, Aguil\u00f3 S, Gil V, Delgado G, Bov\u00e9 A, Font J: Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006, 35: 312-321.","journal-title":"Semin Arthritis Rheum"},{"key":"712_CR56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1191\/0961203305lu2226oa","volume":"14","author":"I Cavazzana","year":"2005","unstructured":"Cavazzana I, Franceschini F, Vassalini C, Danieli E, Quinzanini M, Air\u00f2 P, Cattaneo R: Clinical and serological features of 35 patients with anti-Ki autoantibodies. Lupus. 2005, 14: 837-841.","journal-title":"Lupus"},{"key":"712_CR57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/jaut.1999.0318","volume":"13","author":"H Onouchi","year":"1999","unstructured":"Onouchi H, Muro Y, Tomita Y: Clinical features and IgG subclass distribution of anti-p80 coilin antibodies. J Autoimmun. 1999, 13: 225-232.","journal-title":"J Autoimmun"},{"key":"712_CR58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203308089442","volume":"17","author":"I Cavazzana","year":"2008","unstructured":"Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Air\u00f2 P, Cattaneo R, Franceschini F: Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus. 2008, 17: 727-732.","journal-title":"Lupus"},{"key":"712_CR59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","volume":"12","author":"L Iaccarino","year":"2013","unstructured":"Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, Ghirardello A, Punzi L, Doria A: Overlap connective tissue disease syndromes. Autoimmun Rev. 2013, 12: 363-373.","journal-title":"Autoimmun Rev"},{"key":"712_CR60","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2004.029066","volume":"64","author":"MN Lazarus","year":"2005","unstructured":"Lazarus MN, Isenberg DA: Development of additional autoimmune diseases in a population of patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2005, 64: 1062-1064.","journal-title":"Ann Rheum Dis"},{"key":"712_CR61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","volume":"39","author":"MJ Amador-Patarroyo","year":"2012","unstructured":"Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD, Rodriguez-Rodriguez A, C\u00e1rdenas-Rold\u00e1n J, Pineda-Tamayo R, Guarin MR, Kleine LL, Rojas-Villarraga A, Anaya JM: Sj\u00f6gren\u2019s syndrome at the crossroad of polyautoimmunity. J Autoimmun. 2012, 39: 199-205.","journal-title":"J Autoimmun"},{"key":"712_CR62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","volume":"18","author":"Q Yao","year":"2012","unstructured":"Yao Q, Altman RD, Wang X: Systemic lupus erythematosus with Sj\u00f6gren syndrome compared to systemic lupus erythematosus alone: a meta-analysis. J Clin Rheumatol. 2012, 18: 28-32.","journal-title":"J Clin Rheumatol"},{"key":"712_CR63","first-page":"S231","volume":"14","author":"E Theander","year":"2005","unstructured":"Theander E, Jacobsson LTH: Features of systemic lupus erythematosus in patients with primary Sj\u00f6gren\u2019s syndrome. A cross-sectional analysis of the 11 items of the SLE criteria set and the levels of complement factors C3 and C4 in 100 primary Sj\u00f6gren\u2019s syndrome patients. Lupus. 2005, 14: S231.","journal-title":"Lupus"},{"key":"712_CR64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","volume":"9","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Martel C, Gondran G, Lambert M, Launay D, Jauberteau MO, Hachulla E, Vidal E, Hatron PY: Immunological profile in primary Sj\u00f6gren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev. 2010, 9: 595-599.","journal-title":"Autoimmun Rev"},{"key":"712_CR65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","volume":"62","author":"L Carmona","year":"2003","unstructured":"Carmona L, Gonz\u00e1lez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmart\u00ed R: Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003, 62: 897-900.","journal-title":"Ann Rheum Dis"},{"key":"712_CR66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1563-2571.2002.01043.x","volume":"29","author":"M Skoumal","year":"2002","unstructured":"Skoumal M, Wottawa A: Long-term observation study of Austrian patients with rheumatoid arthritis. Acta Med Austriaca. 2002, 29: 52-56.","journal-title":"Acta Med Austriaca"},{"key":"712_CR67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10067-007-0800-1","volume":"27","author":"I Alexiou","year":"2008","unstructured":"Alexiou I, Germenis A, Koutroumpas A, Kontogianni A, Theodoridou K, Sakkas LI: Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol. 2008, 27: 511-513.","journal-title":"Clin Rheumatol"},{"key":"712_CR68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","volume":"8","author":"M Kauppi","year":"1997","unstructured":"Kauppi M, Pukkala E, Isomaki H: Elevated incidence of hematologic malignancies in patients with Sj\u00f6gren\u2019s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control. 1997, 8: 201-204.","journal-title":"Cancer Causes Control"},{"key":"712_CR69","first-page":"203","volume":"1963","author":"G Rodnan","year":"1963","unstructured":"Rodnan G: The natural history of progressive sclerosis (diffuse scleroderma). Bull Rheum Dis. 1963, 1963: 203-205.","journal-title":"Bull Rheum Dis"},{"key":"712_CR70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(74)90771-2","volume":"57","author":"D Alarc\u00f3n-Segovia","year":"1974","unstructured":"Alarc\u00f3n-Segovia D, Ib\u00e1nez G, Hern\u00e1ndez-Ort\u00edz J, Vel\u00e1zquez-Forero F, Gonz\u00e1lez-Jim\u00e9nez Y: Sj\u00f6gren\u2019s syndrome in progressive systemic sclerosis (scleroderma). Am J Med. 1974, 57: 78-85.","journal-title":"Am J Med"},{"key":"712_CR71","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.21922","volume":"54","author":"J Avouac","year":"2006","unstructured":"Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, Kahan A, Allanore Y: Systemic sclerosis-associated Sj\u00f6gren\u2019s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006, 54: 2243-2249.","journal-title":"Arthritis Rheum"},{"key":"712_CR72","first-page":"2253","volume":"34","author":"C Salliot","year":"2007","unstructured":"Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X: Anticentromere antibodies identify patients with Sj\u00f6gren\u2019s syndrome and autoimmune overlap syndrome. J Rheumatol. 2007, 34: 2253-2258.","journal-title":"J Rheumatol"},{"key":"712_CR73","first-page":"13","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin ME: The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases\u20132008. Isr Med Assoc J. 2008, 10: 13-19.","journal-title":"Isr Med Assoc J"},{"key":"712_CR74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","volume":"30","author":"S Kivity","year":"2009","unstructured":"Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y: Autoimmunity and environment: infections and autoimmunity - friends or foes?. Trends Immunol. 2009, 30: 409-414.","journal-title":"Trends Immunol"},{"key":"712_CR75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2012.01.001","volume":"39","author":"Y Shapira","year":"2012","unstructured":"Shapira Y, Agmon-Levin N, Selmi C, Petr\u00edkov\u00e1 J, Barzilai O, Ram M, Bizzaro N, Valentini G, Matucci-Cerinic M, Anaya JM, Katz BS, Shoenfeld Y: Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012, 39: 112-116.","journal-title":"J Autoimmun"},{"key":"712_CR76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.autrev.2011.04.003","volume":"10","author":"L Sagi","year":"2011","unstructured":"Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, Ram M, Bizzaro N, Sanmarco M, Trau H, Shoenfeld Y: Autoimmune bullous diseases. The spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev. 2011, 10: 527-535.","journal-title":"Autoimmun Rev"},{"key":"712_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2009.08.009","volume":"34","author":"N Agmon-Levin","year":"2010","unstructured":"Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, Sella S, Katz BS, Youinou P, Renaudineau Y, Larida B, Invernizzi P, Gershwin ME, Shoenfeld Y: A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun. 2010, 34: 55-58.","journal-title":"J Autoimmun"},{"key":"712_CR78","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0961203309345738","volume":"18","author":"H Zinger","year":"2009","unstructured":"Zinger H, Sherer Y, Goddard G, Berkun Y, Barzilai O, Agmon-Levin N, Ram M, Blank M, Tincani A, Rozman B, Cervera R, Shoenfeld Y: Common infectious agents prevalence in antiphospholipid syndrome. Lupus. 2009, 18: 1149-1153.","journal-title":"Lupus"},{"key":"712_CR79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1749-6632.2009.04754.x","volume":"1173","author":"G Zandman-Goddard","year":"2009","unstructured":"Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, Sherer Y, Anaya JM, Shoenfeld Y: Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann NY Acad Sci. 2009, 1173: 658-663.","journal-title":"Ann NY Acad Sci"},{"key":"712_CR80","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1749-6632.2009.04673.x","volume":"1173","author":"M Lidar","year":"2009","unstructured":"Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz B, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y: Infectious serologies and autoantibodies in inflammatory bowel diseases. Insinuations at a true pathogenic role. Ann NY Acad Sci. 2009, 1173: 640-648.","journal-title":"Ann NY Acad Sci"},{"key":"712_CR81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","volume":"39","author":"N Agmon-Levin","year":"2012","unstructured":"Agmon-Levin N, Kivity S, Tzioufas AG, L\u00f3pez Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P, Shoenfeld Y: Low levels of vitamin D are associated with neuropathy and lymphoma among patients with Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2012, 39: 234-239.","journal-title":"J Autoimmun"},{"key":"712_CR82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1100\/tsw.2006.25","volume":"6","author":"SJ Kiraly","year":"2006","unstructured":"Kiraly SJ, Kiraly MA, Hawe RD, Makhani N: Vitamin D as a neuroactive substance: review. Scientific World J. 2006, 6: 125-139.","journal-title":"Scientific World J"},{"key":"712_CR83","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1089\/neu.2008.0593","volume":"25","author":"JF Chabas","year":"2008","unstructured":"Chabas JF, Alluin O, Rao G, Garcia S, Lavaut MN, Risso JJ, Legre R, Magalon G, Khrestchatisky M, Marqueste T, Decherchi P, Feron F: Vitamin D2 potentiates axon regeneration. J Neurotrauma. 2008, 25: 1247-1256.","journal-title":"J Neurotrauma"},{"key":"712_CR84","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1526-4637.2008.00415.x","volume":"9","author":"MK Turner","year":"2008","unstructured":"Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK: Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008, 9: 979-984.","journal-title":"Pain Med"},{"key":"712_CR85","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ejim.2011.11.008","volume":"23","author":"S Skalli","year":"2012","unstructured":"Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N: Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med. 2012, 23: e67-e68.","journal-title":"Eur J Intern Med"},{"key":"712_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jdiacomp.2005.05.011","volume":"19","author":"P Valensi","year":"2005","unstructured":"Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, LeFante C: A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complications. 2005, 19: 247-253.","journal-title":"J Diabetes Complications"},{"key":"712_CR87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.168.7.771","volume":"168","author":"P Lee","year":"2008","unstructured":"Lee P, Chen R: Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008, 168: 771-772.","journal-title":"Arch Intern Med"},{"key":"712_CR88","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/annonc\/mdl054","volume":"17","author":"J Polesel","year":"2006","unstructured":"Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S: Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case\u2013control study. Ann Oncol. 2006, 17: 713-718.","journal-title":"Ann Oncol"},{"key":"712_CR89","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/07357900902849632","volume":"27","author":"JL Kelly","year":"2009","unstructured":"Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG: Vitamin D and non-Hodgkin lymphoma risk in adults: a review. Cancer Invest. 2009, 27: 942-951.","journal-title":"Cancer Invest"},{"key":"712_CR90","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bjc.1993.406","volume":"68","author":"T Hickish","year":"1993","unstructured":"Hickish T, Cunningham D, Colston K, Millar BC, Sandle J, Mackay AG, Soukop M, Sloane J: The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer. 1993, 68: 668-672.","journal-title":"Br J Cancer"},{"key":"712_CR91","doi-asserted-by":"crossref","first-page":"J197","DOI":"10.1016\/j.jaut.2011.11.010","volume":"38","author":"L Andreoli","year":"2012","unstructured":"Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A: Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun. 2012, 38: J197-J208.","journal-title":"J Autoimmun"},{"key":"712_CR92","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","volume":"71","author":"A Ambrosi","year":"2012","unstructured":"Ambrosi A, Salomonsson S, Eliasson H, Zeffer E, Skog A, Dzikaite V, Bergman G, Fernlund E, Tingstr\u00f6m J, Theander E, Rydberg A, Skogh T, \u00d6hman A, Lundstr\u00f6m U, Mellander M, Winqvist O, Fored M, Ekbom A, Alfredsson L, K\u00e4llberg H, Olsson T, Gadler F, Jonzon A, Kockum I, Sonesson SE, Wahren-Herlenius M: Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis. 2012, 71: 334-340.","journal-title":"Ann Rheum Dis"},{"key":"712_CR93","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1191\/0961203302lu252oa","volume":"11","author":"A Brucato","year":"2002","unstructured":"Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L, Muscar\u00e0 M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R, Gambari PF, Meroni PL, Canesi B, Tincani A: Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro\/SSA antibodies: a prospective controlled study. Lupus. 2002, 11: 716-721.","journal-title":"Lupus"},{"key":"712_CR94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0301-2115(95)02224-U","volume":"63","author":"D Marchesoni","year":"1995","unstructured":"Marchesoni D, Mozzanega B, De Sandre P, Romagnolo C, Gambari PF, Maggino T: Gynaecological aspects of primary Sj\u00f6gren\u2019s syndrome. Eur J Obstet Gynecol Reprod Biol. 1995, 63: 49-53.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"712_CR95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/03009740510017959","volume":"34","author":"HJ Haga","year":"2005","unstructured":"Haga HJ, Gjesdal CG, Irgens LM, Ostensen M: Reproduction and gynaecological manifestations in women with primary Sj\u00f6gren\u2019s syndrome: a case\u2013control study. Scand J Rheumatol. 2005, 34: 45-48.","journal-title":"Scand J Rheumatol"},{"key":"712_CR96","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00296-009-0850-6","volume":"29","author":"AG Tristano","year":"2009","unstructured":"Tristano AG: The impact of rheumatic diseases on sexual function. Rheumatol Int. 2009, 29: 853-860.","journal-title":"Rheumatol Int"},{"key":"712_CR97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2012.01.004","volume":"39","author":"YT Konttinen","year":"2012","unstructured":"Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y: Sex steroids in Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2012, 39: 49-56.","journal-title":"J Autoimmun"},{"key":"712_CR98","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","volume":"8","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X, Tzioufas AG: Topical and systemic medications for the treatment of primary Sj\u00f6gren\u2019s syndrome. Nat Rev Rheumatol. 2012, 8: 399-411.","journal-title":"Nat Rev Rheumatol"},{"key":"712_CR99","first-page":"CD008934","volume":"7","author":"S Furness","year":"2011","unstructured":"Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R: Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011, 7: CD008934.","journal-title":"Cochrane Database Syst Rev"},{"key":"712_CR100","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","volume":"118","author":"EK Akpek","year":"2011","unstructured":"Akpek EK, Lindsley KB, Adyanthaya RS, Swamy R, Baer AN, McDonnell PJ: Treatment of Sj\u00f6gren\u2019s syndrome-associated dry eye an evidence-based review. Ophthalmology. 2011, 118: 1242-1252.","journal-title":"Ophthalmology"},{"key":"712_CR101","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria A: The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev. 2011, 10: 305-310.","journal-title":"Autoimmun Rev"},{"key":"712_CR102","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/rheumatology\/kep104","volume":"48","author":"M Rihl","year":"2009","unstructured":"Rihl M, Ulbricht K, Schmidt RE, Witte T: Treatment of sicca symptoms with hydroxychloroquine in patients with Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2009, 48: 796-799.","journal-title":"Rheumatology (Oxford)"},{"key":"712_CR103","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00296-010-1415-4","volume":"31","author":"S Yavuz","year":"2011","unstructured":"Yavuz S, Asfuro\u011flu E, Bicakcigil M, Toker E: Hydroxychloroquine improves dry eye symptoms of patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int. 2011, 31: 1045-1049.","journal-title":"Rheumatol Int"},{"key":"712_CR104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","volume":"44","author":"LJ Dawson","year":"2005","unstructured":"Dawson LJ, Caulfield VL, Stanbury JB, Field AE, Christmas SE, Smith PM: Hydroxychloroquine therapy in patients with primary Sj\u00f6gren\u2019s syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford). 2005, 44: 449-455.","journal-title":"Rheumatology (Oxford)"},{"key":"712_CR105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2007.11.004","volume":"7","author":"A Doria","year":"2008","unstructured":"Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P: Preventive strategies in systemic lupus erythematosus. Autoimmun Rev. 2008, 7: 192-197.","journal-title":"Autoimmun Rev"},{"key":"712_CR106","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","volume":"6","author":"L Iaccarino","year":"2007","unstructured":"Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A: Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?. Autoimmun Rev. 2007, 6: 190-195.","journal-title":"Autoimmun Rev"},{"key":"712_CR107","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.autrev.2007.03.009","volume":"6","author":"F Atzeni","year":"2007","unstructured":"Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P: Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev. 2007, 6: 529-536.","journal-title":"Autoimmun Rev"},{"key":"712_CR108","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","volume":"56","author":"CP Mavragani","year":"2007","unstructured":"Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK: Augmented interferon-alpha pathway activation in patients with Sj\u00f6gren\u2019s syndrome treated with etanercept. Arthritis Rheum. 2007, 56: 3995-4004.","journal-title":"Arthritis Rheum"},{"key":"712_CR109","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/art.11109","volume":"49","author":"BG Somer","year":"2003","unstructured":"Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ, American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines: Improvement in Sj\u00f6gren\u2019s syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis Rheum. 2003, 49: 394-398.","journal-title":"Arthritis Rheum"},{"key":"712_CR110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/keh248","volume":"43","author":"M Voulgarelis","year":"2004","unstructured":"Voulgarelis M, Giannouli S, Anagnostou D, Tzioufas AG: Combined therapy with rituximab plus cyclophosphamide\/doxorubicin\/vincristine\/prednisone (CHOP) for Sj\u00f6gren\u2019s syndrome-associated B-cell aggressive non-Hodgkin\u2019s lymphomas. Rheumatology (Oxford). 2004, 43: 1050-1053.","journal-title":"Rheumatology (Oxford)"},{"key":"712_CR111","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI): Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis. 2005, 64: 913-920.","journal-title":"Ann Rheum Dis"},{"key":"712_CR112","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","volume":"52","author":"J Pijpe","year":"2005","unstructured":"Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H: Rituximab treatment in patients with primary Sj\u00f6gren\u2019s syndrome: an open-label phase II study. Arthritis Rheum. 2005, 52: 2740-2750.","journal-title":"Arthritis Rheum"},{"key":"712_CR113","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10067-005-0086-0","volume":"25","author":"T Ring","year":"2006","unstructured":"Ring T, Kallenbach M, Praetorius J, Nielsen S, Melgaard B: Successful treatment of a patient with primary Sj\u00f6gren\u2019s syndrome with rituximab. Clin Rheumatol. 2006, 25: 891-894.","journal-title":"Clin Rheumatol"},{"key":"712_CR114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","volume":"66","author":"R Seror","year":"2007","unstructured":"Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, Candon S, Le Guern V, Aouba A, Sibilia J, Gottenberg JE, Mariette X: Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2007, 66: 351-357.","journal-title":"Ann Rheum Dis"},{"key":"712_CR115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","volume":"57","author":"V Devauchelle-Pensec","year":"2007","unstructured":"Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S, Roudaut A, Jamin C, Renaudineau Y, Rou\u00e9 IQ, Cochener B, Youinou P, Saraux A: Improvement of Sj\u00f6gren\u2019s syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. 2007, 57: 310-317.","journal-title":"Arthritis Rheum"},{"key":"712_CR116","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","volume":"67","author":"S Dass","year":"2008","unstructured":"Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P: Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008, 67: 1541-1544.","journal-title":"Ann Rheum Dis"},{"key":"712_CR117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8028-z","volume":"34","author":"C Galarza","year":"2008","unstructured":"Galarza C, Valencia D, Tob\u00f3n GJ, Zurita L, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Rueda JC, Anaya JM: Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?. Clin Rev Allergy Immunol. 2008, 34: 124-128.","journal-title":"Clin Rev Allergy Immunol"},{"key":"712_CR118","first-page":"468","volume":"28","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Garc\u00eda-Hern\u00e1ndez FJ, de Ram\u00f3n E, Callejas JL, Mart\u00ednez-Berriotxoa A, Pallar\u00e9s L, Caminal-Montero L, Selva-O\u2019Callaghan A, Oristrell J, Hidalgo C, P\u00e9rez-Alvarez R, Mic\u00f3 ML, Medrano F, G\u00f3mez de la Torre R, D\u00edaz-Lagares C, Camps M, Ortego N, S\u00e1nchez-Rom\u00e1n J, BIOGEAS Study Group: Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases. Clin Exp Rheumatol. 2010, 28: 468-476.","journal-title":"Clin Exp Rheumatol"},{"key":"712_CR119","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H: Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010, 62: 960-968.","journal-title":"Arthritis Rheum"},{"key":"712_CR120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","volume":"71","author":"A Mekinian","year":"2012","unstructured":"Mekinian A, Ravaud P, Hatron PY, Larroche C, Leone J, Gombert B, Hamidou M, Cantagrel A, Marcelli C, Rist S, Breban M, Launay D, Fain O, Gottenberg JE, Mariette X: Efficacy of rituximab in primary Sj\u00f6gren\u2019s syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis. 2012, 71: 84-87.","journal-title":"Ann Rheum Dis"},{"key":"712_CR121","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2007.02.004","volume":"6","author":"F Atzeni","year":"2007","unstructured":"Atzeni F, Doria A, Turiel M, Sarzi-Puttini P: What is the role of rituximab in the treatment of rheumatoid arthritis?. Autoimmun Rev. 2007, 6: 553-558.","journal-title":"Autoimmun Rev"},{"key":"712_CR122","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/annrheumdis-2011-201189","volume":"71","author":"N Hamza","year":"2012","unstructured":"Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA: Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome after B cell depletion therapy. Ann Rheum Dis. 2012, 71: 1881-1887.","journal-title":"Ann Rheum Dis"},{"key":"712_CR123","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2018","volume":"8","author":"SD Steinfeld","year":"2006","unstructured":"Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O: Epratuzumab (humanised anti-CD22 antibody) in primary Sj\u00f6gren\u2019s syndrome: an open-label phase I\/II study. Arthritis Res Ther. 2006, 8: R129.","journal-title":"Arthritis Res Ther"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-11-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T09:44:33Z","timestamp":1715161473000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-11-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-11-93","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]},"article-number":"93"}}